Manganese dioxide nanozyme alleviates PEDV GIIc-associated growth retardation in neonatal piglets by improving antioxidant status, intestinal morphology, and manganese homeostasis.
- 1Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu, China.
- 2Key Laboratory for Animal Disease-Resistance Nutrition of China Ministry of Education, Sichuan Agricultural University, Chengdu, China.
Abstract
Introduction
Porcine epidemic diarrhea virus (PEDV) infection threatens swine production, and growth retardation in neonatal piglets born to infected sows requires practical intervention. This study evaluated the effects of oral manganese dioxide (MnO₂) nanozyme supplementation on growth and physiological indices in these piglets.Methods
In this study, 16 litters from PEDV GIIc-infected sows were assigned to four treatment groups according to body condition and PEDV RT-qPCR Ct value, with four litters from uninfected sows used as the negative control (NC). From 3 d of age to 21 d of age, piglets from PEDV-infected sows received oral MnO₂ nanozyme at different concentrations every other day.Results
Compared with NC group, PEDV-positive control (PC) group had lower average daily gain and jejunal villus height (P < 0.05), decreased serum CAT activity and serum GSH concentration, reduced jejunal GSH concentration, altered manganese transporter expression in the duodenum, and increased hepatic manganese accumulation. In piglets, oral MnO₂ nanozyme restored average daily gain to normal levels, improved jejunal villus height, and maintained GSH concentrations in serum, jejunum, and liver at levels not different from NC. MnO₂ nanozyme administration also increased duodenal DMT1 expression, decreased hepatic expression of transporters such as ZIP8, tended to increase duodenal manganese content, reduced hepatic manganese-transporter expression relative to the PC group, and alleviated hepatic manganese accumulation. In rectal fecal samples from piglets, MnO₂ nanozyme increased the relative abundance of beneficial bacterial genera, including Prevotella and Bifidobacterium.Discussion
Oral MnO₂ nanozyme supplementation was associated with alleviation of PEDV GIIc-associated growth retardation and changes in intestinal morphology, antioxidant status, and manganese-related indices. The 5 mg/L group showed a favorable growth response at the lowest tested concentration. Baseline body-weight differences should be considered when interpreting these findings, and further controlled studies are needed to establish the underlying mechanisms and optimal administration regimen.
Related
- KARAP deficiency alleviates intestinal mucosal barrier dysfunction by regulating mitochondrial homeostasis in macrophages.
- Exogenous 24-Epibrassinolide Alleviates Postharvest Chilling Injury in Green Pepper Fruit Associated with Enhanced Antioxidant Defense and Reduced Membrane Damage
- Oral inulin prebiotic encapsulating Cortex Fraxini extracellular vesicles alleviates colitis and associated renal stress via reinforcing intestinal barriers and remodeling microbiota.
- Dietary Sanguinarine Enhances Antioxidant Capacity and Intestinal Barrier Function in Yellow-Feathered Broilers via Modulation of Microbiota-Associated Butyrate Signaling.
- Effects of dietary nisin on growth performance, meat quality, antioxidant status, and microbial homeostasis in broilers
BibTeX
@article{wang2026manganese,
title = {{Manganese dioxide nanozyme alleviates PEDV GIIc-associated growth retardation in neonatal piglets by improving antioxidant status, intestinal morphology, and manganese homeostasis.}},
author = {Jintao Wang and Xin Lai and Mingfang Hu and Sheng Liang and Tianci Wu and Xiyin Fan and Yuheng Luo and Jun He and Lianqiang Che and Daiwen Chen and Aimin Wu},
journal = {Frontiers in veterinary science},
year = {2026},
month = oct,
doi = {10.3389/fvets.2026.1963407},
url = {https://europepmc.org/article/MED/42903197},
note = {CC BY},
}
RIS
TY - JOUR
TI - Manganese dioxide nanozyme alleviates PEDV GIIc-associated growth retardation in neonatal piglets by improving antioxidant status, intestinal morphology, and manganese homeostasis.
AU - Jintao Wang
AU - Xin Lai
AU - Mingfang Hu
AU - Sheng Liang
AU - Tianci Wu
AU - Xiyin Fan
AU - Yuheng Luo
AU - Jun He
AU - Lianqiang Che
AU - Daiwen Chen
AU - Aimin Wu
PY - 2026
DA - 2026/10/06
JO - Frontiers in veterinary science
DO - 10.3389/fvets.2026.1963407
UR - https://europepmc.org/article/MED/42903197
AB - Introduction Porcine epidemic diarrhea virus (PEDV) infection threatens swine production, and growth retardation in neonatal piglets born to infected sows requires practical intervention. This study evaluated the effects of oral manganese dioxide (MnO₂) nanozyme supplementation on growth and physiological indices in these piglets.Methods In this study, 16 litters from PEDV GIIc-infected sows were assigned to four treatment groups according to body condition and PEDV RT-qPCR Ct value, with four litters from uninfected sows used as the negative control (NC). From 3 d of age to 21 d of age, piglets from PEDV-infected sows received oral MnO₂ nanozyme at different concentrations every other day.Results Compared with NC group, PEDV-positive control (PC) group had lower average daily gain and jejunal villus height (P < 0.05), decreased serum CAT activity and serum GSH concentration, reduced jejunal GSH concentration, altered manganese transporter expression in the duodenum, and increased hepatic manganese accumulation. In piglets, oral MnO₂ nanozyme restored average daily gain to normal levels, improved jejunal villus height, and maintained GSH concentrations in serum, jejunum, and liver at levels not different from NC. MnO₂ nanozyme administration also increased duodenal DMT1 expression, decreased hepatic expression of transporters such as ZIP8, tended to increase duodenal manganese content, reduced hepatic manganese-transporter expression relative to the PC group, and alleviated hepatic manganese accumulation. In rectal fecal samples from piglets, MnO₂ nanozyme increased the relative abundance of beneficial bacterial genera, including Prevotella and Bifidobacterium.Discussion Oral MnO₂ nanozyme supplementation was associated with alleviation of PEDV GIIc-associated growth retardation and changes in intestinal morphology, antioxidant status, and manganese-related indices. The 5 mg/L group showed a favorable growth response at the lowest tested concentration. Baseline body-weight differences should be considered when interpreting these findings, and further controlled studies are needed to establish the underlying mechanisms and optimal administration regimen.
SN - 2297-1769
ER -